Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Enhancement of musculocutaneous nerve reinnervation after vascular endothelial growth factor (VEGF) gene therapy

P. Haninec, R. Kaiser, V. Bobek, P. Dubový,

. 2012 ; 13 () : 57.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Vascular endothelial growth factor (VEGF) is not only a potent angiogenic factor but it also promotes axonal outgrowth and proliferation of Schwann cells. The aim of the present study was to quantitatively assess reinnervation of musculocutaneous nerve (MCN) stumps using motor and primary sensory neurons after plasmid phVEGF transfection and end-to-end (ETE) or end-to-side (ETS) neurorrhaphy. The distal stump of rat transected MCN, was transfected with plasmid phVEGF, plasmid alone or treated with vehiculum and reinnervated following ETE or ETS neurorrhaphy for 2 months. The number of motor and dorsal root ganglia neurons reinnervating the MCN stump was estimated following their retrograde labeling with Fluoro-Ruby and Fluoro-Emerald. Reinnervation of the MCN stumps was assessed based on density, diameter and myelin sheath thickness of regenerated axons, grooming test and the wet weight index of the biceps brachii muscles. RESULTS: Immunohistochemical detection under the same conditions revealed increased VEGF in the Schwann cells of the MCN stumps transfected with the plasmid phVEGF, as opposed to control stumps transfected with only the plasmid or treated with vehiculum. The MCN stumps transfected with the plasmid phVEGF were reinnervated by moderately higher numbers of motor and sensory neurons after ETE neurorrhaphy compared with control stumps. However, morphometric quality of myelinated axons, grooming test and the wet weight index were significantly better in the MCN plasmid phVEGF transfected stumps. The ETS neurorrhaphy of the MCN plasmid phVEGF transfected stumps in comparison with control stumps resulted in significant elevation of motor and sensory neurons that reinnervated the MCN. Especially noteworthy was the increased numbers of neurons that sent out collateral sprouts into the MCN stumps. Similarly to ETE neurorrhaphy, phVEGF transfection resulted in significantly higher morphometric quality of myelinated axons, behavioral test and the wet weight index of the biceps brachii muscles. CONCLUSION: Our results showed that plasmid phVEGF transfection of MCN stumps could induce an increase in VEGF protein in Schwann cells, which resulted in higher quality axon reinnervation after both ETE and ETS neurorrhaphy. This was also associated with a better wet weight biceps brachii muscle index and functional tests than in control rats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13000747
003      
CZ-PrNML
005      
20130204115227.0
007      
ta
008      
130108s2012 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/1471-2202-13-57 $2 doi
035    __
$a (PubMed)22672575
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Haninec, Pavel $u Department of Neurosurgery, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Enhancement of musculocutaneous nerve reinnervation after vascular endothelial growth factor (VEGF) gene therapy / $c P. Haninec, R. Kaiser, V. Bobek, P. Dubový,
520    9_
$a BACKGROUND: Vascular endothelial growth factor (VEGF) is not only a potent angiogenic factor but it also promotes axonal outgrowth and proliferation of Schwann cells. The aim of the present study was to quantitatively assess reinnervation of musculocutaneous nerve (MCN) stumps using motor and primary sensory neurons after plasmid phVEGF transfection and end-to-end (ETE) or end-to-side (ETS) neurorrhaphy. The distal stump of rat transected MCN, was transfected with plasmid phVEGF, plasmid alone or treated with vehiculum and reinnervated following ETE or ETS neurorrhaphy for 2 months. The number of motor and dorsal root ganglia neurons reinnervating the MCN stump was estimated following their retrograde labeling with Fluoro-Ruby and Fluoro-Emerald. Reinnervation of the MCN stumps was assessed based on density, diameter and myelin sheath thickness of regenerated axons, grooming test and the wet weight index of the biceps brachii muscles. RESULTS: Immunohistochemical detection under the same conditions revealed increased VEGF in the Schwann cells of the MCN stumps transfected with the plasmid phVEGF, as opposed to control stumps transfected with only the plasmid or treated with vehiculum. The MCN stumps transfected with the plasmid phVEGF were reinnervated by moderately higher numbers of motor and sensory neurons after ETE neurorrhaphy compared with control stumps. However, morphometric quality of myelinated axons, grooming test and the wet weight index were significantly better in the MCN plasmid phVEGF transfected stumps. The ETS neurorrhaphy of the MCN plasmid phVEGF transfected stumps in comparison with control stumps resulted in significant elevation of motor and sensory neurons that reinnervated the MCN. Especially noteworthy was the increased numbers of neurons that sent out collateral sprouts into the MCN stumps. Similarly to ETE neurorrhaphy, phVEGF transfection resulted in significantly higher morphometric quality of myelinated axons, behavioral test and the wet weight index of the biceps brachii muscles. CONCLUSION: Our results showed that plasmid phVEGF transfection of MCN stumps could induce an increase in VEGF protein in Schwann cells, which resulted in higher quality axon reinnervation after both ETE and ETS neurorrhaphy. This was also associated with a better wet weight biceps brachii muscle index and functional tests than in control rats.
650    _2
$a zvířata $7 D000818
650    _2
$a dextrany $x diagnostické užití $7 D003911
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluoresceiny $x diagnostické užití $7 D005452
650    _2
$a přední končetina $x patofyziologie $7 D005552
650    _2
$a genetická terapie $x metody $7 D015316
650    _2
$a nervus musculocutaneus $x metabolismus $x patologie $x fyziologie $7 D009138
650    _2
$a nervová vlákna myelinizovaná $x patologie $7 D009413
650    _2
$a regenerace nervu $x genetika $x fyziologie $7 D009416
650    _2
$a neurologické vyšetření $7 D009460
650    _2
$a neurony $x metabolismus $x patologie $7 D009474
650    _2
$a velikost orgánu $x fyziologie $7 D009929
650    _2
$a nemoci periferního nervového systému $x patologie $x terapie $7 D010523
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a rhodaminy $x diagnostické užití $7 D012235
650    _2
$a mícha $x patologie $7 D013116
650    _2
$a vaskulární endoteliální růstový faktor A $x biosyntéza $x metabolismus $x terapeutické užití $7 D042461
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kaiser, Radek
700    1_
$a Bobek, Vladimír
700    1_
$a Dubový, Petr
773    0_
$w MED00008196 $t BMC neuroscience $x 1471-2202 $g Roč. 13(2012), s. 57
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22672575 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130108 $b ABA008
991    __
$a 20130204115359 $b ABA008
999    __
$a ok $b bmc $g 963529 $s 798911
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 13 $d 57 $i 1471-2202 $m BMC neuroscience $n BMC Neurosci $x MED00008196
LZP    __
$a Pubmed-20130108

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...